Chemical formula: C₁₃H₂₀N₂O₂ Molecular mass: 236.315 g/mol PubChem compound: 65859
Teratogenesis, reproduction and fertility studies as well as peri- and post-natal studies did not reveal any specific toxic effect. Nevertheless, as in animal toxicology studies with the 24 mg/kg dose a mild delay in the body weight increase and in growth has been observed and as levodropropizin is able to cross the placental barrier in the rat, the drug is contraindicated in women wanting to get pregnant or already pregnant as its safety of use is not documented.
Studies in rats show that the drug can be found in the mother’s milk until 8 hours after administration. Thus, the drug is contraindicated during lactation.
Studies have not been performed on the ability to drive and/or the use of machines. Nevertheless, as levodropropizine may rarely cause sleepiness caution must be used in patients who intend to drive or use machines, informing them about this possibility.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
